What question did this study set out to answer?

The aim is to evaluate the effectiveness of [68Ga]Ga-FAPI-46 PET/CT in diagnosing adrenocortical neoplasm, oncocytic type.

March 29, 2026Journal of Nuclear Medicine0 citations

68 GaGa-FAPI-46 PET/CT in Adrenocortical Neoplasm, Oncocytic Type

KKKoichiro KimuraMolecular Theranostics (United States)MLMasha J. LivhitsUniversity of California, Los Angeles ILIsraa LakloukUniversity of California, Los Angeles

Key Points

The aim is to evaluate the effectiveness of [68Ga]Ga-FAPI-46 PET/CT in diagnosing adrenocortical neoplasm, oncocytic type.
Utilized [68Ga]Ga-FAPI-46 PET/CT imaging.
Focused on cases of adrenocortical neoplasms, particularly oncocytic types.
Categorized tumors based on benign, borderline, and malignant status.
Identified variations in imaging patterns among the different tumor classifications.
Demonstrated potential for PET/CT to distinguish between benign and malignant tumors.
Reported a favorable outcome in the identification of borderline lesions.

Abstract

Adrenocortical neoplasm, oncocytic type (ACNO), known as adrenal oncocytoma, is a rare histologic subtype of adrenocortical neoplasms. Approximately one third of ACNOs are benign, 40% are borderline, and one fourth are malignant (11). Although benign and borderline ACNOs have a favorable

AI से पूछें

Bookmark

View Full Paper